Skip to main content

SHAREHOLDER ALERT: Robbins LLP Investigates Natera, Inc. (NTRA) on Behalf of Shareholders

Shareholder rights law firm Robbins LLP is investigating Natera, Inc. (NASDAQ: NTRA) to determine whether certain Natera officers and directors violated securities laws and breached fiduciary duties to shareholders. Natera develops and commercializes molecular testing, including a non-invasive prenatal test that screens for chromosomal abnormalities.

If you would like more information about our investigation of Natera, Inc.'s misconduct, click here.

Natera, Inc.'s (NTRA) Prenatal Tests May be Inaccurate

On January 1, 2022, an article from the New York Times called into question the accuracy of certain noninvasive prenatal tests, including that developed by Natera. The article alleges that positive results on tests are incorrect about 85% percent of the time. Patients who receive a positive result are supposed to pursue follow-up testing, which are expensive, invasive and cannot be performed until later in pregnancy. The investigation highlights the statistical challenge of testing from things that are extremely rare. But, this isn't adequately explained to patients who were sold the tests. Companies that develop these tests use language like "highly accurate" and "total confidence," do not publish data on their tests' overall performance, or only stress data from tests that are more accurate.

On this news, Natera's stock declined as much as 3.5% during intraday trading on January 3, 2022, injuring investors.

Natera, Inc. (NTRA) shareholders have legal options. If you own shares of Natera, Inc. contact us for more information about your legal options.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas

(800) 350-6003

Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Natera, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.